FREDRICK ISAACS, M.D., P.C., F.A.C.S.
Specialist · SILVER SPRING, MD
Individual Active NPI 1588772594
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 743 | 6,956 | $1,164,216 | $752,063 | $575,219 |
| 2023 | 822 | 7,162 | $1,131,041 | $717,235 | $531,755 |
| 2022 | 857 | 7,160 | $1,175,344 | $758,995 | $560,497 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| 92134 | Imaging of retina | 1,087 | $48 | $35 |
| 92012 | Established patient problem focused exam of visual system | 771 | $106 | $78 |
| 76514 | Ultrasound scan of cornea to determine thickness | 764 | $13 | $10 |
| 92083 | Exam of visual field with extended testing | 568 | $75 | $55 |
| 92014 | Established patient complete exam of visual system | 545 | $149 | $107 |
| 92133 | Imaging of optic nerve | 532 | $43 | $31 |
| 92250 | Photography of the retina | 521 | $44 | $33 |
| 67028 | Injection of drug into eye | 297 | $133 | $105 |
| J0178 | Injection, aflibercept, 1 mg | 286 | $827 | $655 |
| 99214 | Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 252 | $150 | $120 |
| J9035 | Injection, bevacizumab, 10 mg | 120 | $72 | $54 |
| 99204 | New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more | 82 | $193 | $140 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Specialist | 174400000X | ✓ | D0054918 | MD |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Specialist providers in Maryland
- NPI 1912931270
- NPI 1205033206
- NPI 1437237468
- NPI 1154480796
- NPI 1912931643
- NPI 1316969025
- NPI 1881424562
- NPI 1376573329
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.